Supplements and Wearable Recovery Scores: What the Research Can—and Can't—Tell You

Can a supplement improve your recovery? Sometimes—when it addresses a deficiency or a problem the supplement has actually been studied for. That is different from proving it will increase a WHOOP Recovery score, Oura Readiness score, Garmin Body Battery, or Apple Watch sleep stage.

Most supplement trials cited below did not test consumer wearable scores. Consumer devices estimate sleep and recovery from proprietary algorithms, and the American Academy of Sleep Medicine says they should not be used to diagnose or treat a sleep disorder.¹ A change on your dashboard can be useful context, but it is not proof that a supplement worked.

This review separates three questions:

1. What outcome did the research measure?
2. How certain is the evidence?
3. What safety checks belong before an experiment?

Before taking a supplement

Supplements can interact with medications and medical conditions. Product quality and the amount of active ingredient also vary.

Talk with a clinician or pharmacist before supplementing if you are pregnant or breastfeeding, have kidney, liver, thyroid, autoimmune, bleeding, or heart-rhythm concerns, take prescription medication, or are preparing for surgery. Athletes subject to drug testing should choose independently certified products.

Do not use a wearable score to override symptoms or medical advice. Persistent insomnia, chest symptoms, fainting, substantial mood changes, or unexplained fatigue deserve clinical assessment.

Magnesium: promising signals, uncertain sleep evidence

Magnesium is involved in hundreds of biological processes, and low intake is common in the United States.² That makes adequacy important. It does not make magnesium a proven wearable-score enhancer.

One double-blind trial gave older adults with primary insomnia 500 mg of supplemental magnesium daily for eight weeks and reported improvements in several sleep measures.³ However, a later systematic review found that randomized-trial results were mixed and inconclusive.⁴ The evidence does not support a promised percentage increase in deep sleep, a guaranteed two-week response, or a claim that magnesium is the single best sleep supplement.

The research also does not establish that glycinate or threonate is superior for sleep, or that taking either form 30–60 minutes before bed is necessary.

Magnesium safety

Check the label for elemental magnesium, not only the compound’s total weight. The U.S. adult upper limit for magnesium from supplements and medications is 350 mg per day unless a clinician recommends otherwise; magnesium naturally present in food does not count toward that limit.² Supplemental magnesium can cause diarrhea and interact with some antibiotics and bisphosphonates. Impaired kidney function increases the risk of magnesium toxicity.²

The 500 mg research dose above should therefore be read as a study detail, not copied as a general recommendation.

Omega-3: no demonstrated rMSSD increase

Omega-3 fatty acids affect cell membranes and inflammatory signaling, but the wearable claim needs precision.

A meta-analysis of randomized fish-oil trials found an increase in high-frequency HRV power. It found no significant effect on rMSSD or SDNN, two time-domain measures commonly discussed in wearable reporting.⁵ A separate study in healthy men linked a higher omega-3 index with improved heart-rate recovery after exercise, which is not the same outcome as overnight wearable HRV.⁶

The evidence therefore does not justify predicting a 3–8 millisecond rMSSD increase. It also does not establish that a universal 2–3 gram EPA+DHA dose is appropriate.

If omega-3 is being considered for dietary or clinical reasons, discuss the product and dose with a clinician—especially when using anticoagulants or managing a heart-rhythm condition.⁷ Evaluate the goal directly rather than treating a higher wearable number as the goal.

Tart cherry: small studies, limited certainty

Tart cherry products contain anthocyanins and small amounts of melatonin. A marathon study reported differences in oxidative-stress markers and muscle-function recovery after participants consumed tart cherry juice around the event.⁸

Sleep evidence is much smaller. One pilot studied older adults with insomnia and reported a modest reduction in wake after sleep onset.⁹ A later placebo-controlled pilot reported a larger increase in total sleep time, but only eight participants completed the study.¹⁰ That sample is too small to promise an 84-minute benefit or a 5–7-day wearable response for the general population.

The later pilot used 240 mL of juice twice daily.¹⁰ That is a study exposure, not a universal prescription. Concentrates can still contain substantial sugar and calories; check the specific label.

Ashwagandha: extract-specific, short-term evidence

Several small randomized trials reported improvements in stress measures, serum cortisol, or sleep quality in selected adults using particular ashwagandha extracts for roughly six to eight weeks.¹¹¹²¹³ Those findings do not show that HRV variability diagnoses a stress-axis disorder, nor do they identify who should take ashwagandha.

Products differ in plant part, extract, and concentration. Results from one standardized extract should not be generalized to every supplement on a shelf.

The National Center for Complementary and Integrative Health says short-term use may be tolerated by some people but notes rare liver injury and important precautions.¹⁴ Ashwagandha should be avoided during pregnancy and breastfeeding and may be inappropriate with thyroid or autoimmune disorders, before surgery, or alongside several medication classes.¹⁴ Discuss it with a clinician rather than using a wearable trend to self-diagnose high cortisol.

Creatine: useful evidence, but not for sleep scores

Creatine monohydrate has extensive evidence for strength and high-intensity exercise, and an expert position stand describes daily use as generally safe for healthy people.¹⁵

One sleep-deprivation experiment gave participants 5 grams four times daily for seven days before 24 hours without sleep and intermittent exercise. The creatine group performed better on some cognitive and psychomotor measures than placebo.¹⁶ That unusual short-term dose does not prove that an everyday 3–5 gram routine improves sleep, HRV, or a wearable recovery score.

Creatine may still fit a training or nutrition plan. It should be evaluated for those goals, not sold as a sleep-stage intervention. People with kidney disease or other relevant conditions should get individualized medical advice.

Vitamin D, CBD, and deficiency-focused supplements

Vitamin D

Vitamin D is important for health, but dose should not be guessed from a recovery score. The NIH notes that a serum 25(OH)D level of 20 ng/mL or more is sufficient for most people, while levels above 50 ng/mL can be associated with adverse effects. The adult upper intake level is 4,000 IU per day unless a clinician directs otherwise.¹⁷

Testing and treatment decisions depend on risk factors and clinical context. Avoid treating 30 or 60 ng/mL as universal performance thresholds, and do not normalize 5,000 IU daily without professional guidance.

CBD

An open-label case series reported early improvements in anxiety and sleep scores for some patients, but sleep results fluctuated and there was no randomized control group.¹⁸ That design cannot establish efficacy. The FDA warns that CBD can affect other medications and carries additional safety uncertainties.¹⁹ This evidence is not enough for a recovery recommendation.

What a wearable can and cannot tell you

HRV can be useful for monitoring within-person trends when measurement conditions are consistent. Researchers often recommend looking at rolling patterns rather than reacting to one morning.²⁰ Even then, HRV is affected by training, illness, alcohol, sleep, hydration, measurement error, and many other factors.

Wearable sleep stages are estimates. A rising deep-sleep percentage after starting a supplement does not isolate the cause, and a flat score does not prove the supplement is irrelevant to every health outcome.

Use the device as a diary with sensors—not as a laboratory or clinician.

A safer personal tracking protocol

This is an observational self-tracking approach, not a causal experiment:

1. Define the real goal. Examples include fewer awakenings, improved daytime alertness, or correcting a laboratory-confirmed deficiency. Do not define success only as a higher proprietary score.
2. Review safety first. Check medications, conditions, pregnancy status, product certification, dose, and whether the supplement is appropriate at all.
3. Keep other factors stable when practical. Record training load, alcohol, illness, travel, bedtime, and medication changes.
4. Change one nonessential supplement at a time. Do not stop or alter prescribed treatment for an experiment.
5. Compare several weeks of trends and symptoms. Treat the result as exploratory because expectation effects, regression to the mean, and device-algorithm changes remain.
6. Stop for adverse effects. Seek medical advice rather than waiting for the wearable to confirm a problem.

Blinding, randomization, and repeated treatment periods would make an N-of-1 design more informative, but most home tracking does not include those controls. Do not call a before-and-after comparison proof.

Evidence summary

Supplement	What the cited evidence measured	What it does not establish
Magnesium	Sleep outcomes in small studies; mixed trial evidence overall	A guaranteed deep-sleep increase or universal bedtime dose
Omega-3	High-frequency HRV power and heart-rate recovery in separate research	A predictable rMSSD increase
Tart cherry	Exercise-recovery markers and very small insomnia pilots	A general 84-minute sleep gain or rapid wearable response
Ashwagandha	Short-term stress, cortisol, and sleep outcomes with specific extracts	HRV diagnosis, long-term safety, or universal benefit
Creatine	Exercise outcomes and cognition in an unusual sleep-deprivation study	Better sleep stages or recovery scores
Vitamin D	Nutritional status and health outcomes	A wearable-based dose
CBD	Uncontrolled clinical case-series outcomes	Proven sleep or recovery efficacy

There is no evidence-based tier that places everyone on the same stack. Deficiency, symptoms, diet, medications, goals, and risk determine whether any option belongs in the conversation.

How SensAI uses recovery data

SensAI can provide daily recovery and readiness summaries using aggregated recovery metrics, sleep quality, and workout history. It can compare trends with your personal baseline and discuss them through its LLM-powered coach.

It does not diagnose a deficiency, cortisol disorder, or supplement response from HRV. It does not run an automated supplement trial. Raw HealthKit data stays on your device; only aggregated metrics and summaries are sent server-side for AI coaching.

If you choose to track a clinician-approved supplement, use SensAI’s trends as context alongside symptoms and professional advice—not as proof of cause and effect.

The bottom line

The strongest conclusion is not that a particular supplement will raise your recovery score. It is that evidence, safety, and the reason for taking it matter more than the dashboard.

Correct a real deficiency. Use studied outcomes rather than influencer promises. Change one thing at a time when appropriate. Let wearables show patterns, but do not ask them to diagnose or prescribe.

---

References

Footnotes

1. American Academy of Sleep Medicine. “Consumer Sleep Technology: An American Academy of Sleep Medicine Position Statement.” American Academy of Sleep Medicine, 2018. https://aasm.org/advocacy/position-statements/consumer-sleep-technology/ ↩

2. National Institutes of Health, Office of Dietary Supplements. “Magnesium: Health Professional Fact Sheet.” National Institutes of Health, updated 2024. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ ↩ ↩² ↩³

3. Abbasi B, Kimiagar M, Sadeghniiat K, et al. “The Effect of Magnesium Supplementation on Primary Insomnia in Elderly: A Double-Blind Placebo-Controlled Clinical Trial.” Journal of Research in Medical Sciences, 2012. https://pubmed.ncbi.nlm.nih.gov/23853635/ ↩

4. Arab A, Rafie N, Amani R, Shirani F. “The Role of Magnesium in Sleep Health: A Systematic Review of Available Literature.” Biological Trace Element Research, 2023. https://pubmed.ncbi.nlm.nih.gov/35184264/ ↩

5. Xin W, Wei W, Li X. “Short-Term Effects of Fish-Oil Supplementation on Heart Rate Variability in Humans: A Meta-Analysis of Randomized Controlled Trials.” American Journal of Clinical Nutrition, 2013. https://pubmed.ncbi.nlm.nih.gov/23515005/ ↩

6. Macartney MJ, Hingley L, Brown MA, Peoples GE, McLennan PL. “Intrinsic Heart Rate Recovery After Dynamic Exercise Is Improved With an Increased Omega-3 Index in Healthy Males.” British Journal of Nutrition, 2014. https://pubmed.ncbi.nlm.nih.gov/25355484/ ↩

7. National Institutes of Health, Office of Dietary Supplements. “Omega-3 Fatty Acids: Health Professional Fact Sheet.” National Institutes of Health, accessed 2026. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ ↩

8. Howatson G, McHugh MP, Hill JA, et al. “Influence of Tart Cherry Juice on Indices of Recovery Following Marathon Running.” Scandinavian Journal of Medicine & Science in Sports, 2010. https://pubmed.ncbi.nlm.nih.gov/19883392/ ↩

9. Pigeon WR, Carr M, Gorman C, Perlis ML. “Effects of a Tart Cherry Juice Beverage on the Sleep of Older Adults With Insomnia: A Pilot Study.” Journal of Medicinal Food, 2010. https://pubmed.ncbi.nlm.nih.gov/20438325/ ↩

10. Losso JN, Finley JW, Karki N, et al. “Pilot Study of the Tart Cherry Juice for the Treatment of Insomnia and Investigation of Mechanisms.” American Journal of Therapeutics, 2018. https://pubmed.ncbi.nlm.nih.gov/28901958/ ↩ ↩²

11. Chandrasekhar K, Kapoor J, Anishetty S. “A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults.” Indian Journal of Psychological Medicine, 2012. https://pubmed.ncbi.nlm.nih.gov/23439798/ ↩

12. Lopresti AL, Smith SJ, Malvi H, Kodgule R. “An Investigation Into the Stress-Relieving and Pharmacological Actions of an Ashwagandha Extract: A Randomized, Double-Blind, Placebo-Controlled Study.” Medicine, 2019. https://pubmed.ncbi.nlm.nih.gov/31517876/ ↩

13. Salve J, Pate S, Debnath K, Langade D. “Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Clinical Study.” Cureus, 2019. https://pubmed.ncbi.nlm.nih.gov/32021735/ ↩

14. National Center for Complementary and Integrative Health. “Ashwagandha: Usefulness and Safety.” National Institutes of Health, accessed 2026. https://www.nccih.nih.gov/health/ashwagandha ↩ ↩²

15. Kreider RB, Kalman DS, Antonio J, et al. “International Society of Sports Nutrition Position Stand: Safety and Efficacy of Creatine Supplementation in Exercise, Sport, and Medicine.” Journal of the International Society of Sports Nutrition, 2017. https://pubmed.ncbi.nlm.nih.gov/28615996/ ↩

16. McMorris T, Harris RC, Swain J, et al. “Effect of Creatine Supplementation and Sleep Deprivation, With Mild Exercise, on Cognitive and Psychomotor Performance, Mood State, and Plasma Concentrations of Catecholamines and Cortisol.” Psychopharmacology, 2006. https://pubmed.ncbi.nlm.nih.gov/16416332/ ↩

17. National Institutes of Health, Office of Dietary Supplements. “Vitamin D: Health Professional Fact Sheet.” National Institutes of Health, accessed 2026. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ ↩

18. Shannon S, Lewis N, Lee H, Hughes S. “Cannabidiol in Anxiety and Sleep: A Large Case Series.” The Permanente Journal, 2019. https://pubmed.ncbi.nlm.nih.gov/30624194/ ↩

19. U.S. Food and Drug Administration. “What You Need to Know About Products Containing Cannabis or Cannabis-Derived Compounds, Including CBD.” U.S. Food and Drug Administration, 2020. https://www.fda.gov/consumers/consumer-updates/what-you-need-know-and-what-were-working-find-out-about-products-containing-cannabis-or-cannabis ↩

20. Plews DJ, Laursen PB, Stanley J, Kilding AE, Buchheit M. “Training Adaptation and Heart Rate Variability in Elite Endurance Athletes: Opening the Door to Effective Monitoring.” Sports Medicine, 2013. https://pubmed.ncbi.nlm.nih.gov/23852425/ ↩